Skip to content

Immunocore

US · IMCR #2968 by market cap Listed 2021
26.41 -0.22 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:10

Quant vs Street three independent views, side by side

StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 56.80 +115.1%
Price target rangecurrent 26.41
Low33.00
Avg56.80
High80.00
Buy 60% Hold 40% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Morgan Stanley -- Hold 42.00
2026-11-12 Goldman Sachs -- Buy 79.00
2026-11-10 H.C. Wainwright -- Buy 80.00
2026-11-09 Morgan Stanley -- Hold 43.00
2026-11-04 H.C. Wainwright -- Buy 100.00
2026-10-29 Mizuho Securities -- Hold 33.00
2026-10-28 Goldman Sachs -- Buy --
2026-10-27 H.C. Wainwright -- Buy 100.00
2026-10-26 H.C. Wainwright -- Buy 100.00
2026-10-22 Morgan Stanley -- Hold 43.00
2026-09-21 H.C. Wainwright -- Buy 100.00
2026-08-21 J.P. Morgan -- Buy 50.00
2026-08-12 H.C. Wainwright -- Buy 100.00
2026-08-07 Mizuho Securities -- Hold 35.00
2026-08-07 Morgan Stanley -- Hold 43.00
2026-08-06 Needham -- Buy 75.00
2026-08-06 Goldman Sachs -- Buy 74.00
2026-06-03 H.C. Wainwright -- Buy 100.00
2026-06-01 Needham -- Buy 75.00
2026-05-22 H.C. Wainwright -- Buy 100.00
2026-05-08 Mizuho Securities -- Hold 34.00
2026-05-08 H.C. Wainwright -- Buy 100.00
2026-05-07 Goldman Sachs -- Buy 73.00
2026-05-07 H.C. Wainwright -- Buy 100.00
2026-05-06 TD Cowen -- Buy 60.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-06 -- ±14.51% +3.63% (in line)
2025/Q4 2026-02-25 -- ±14.99% -4.51% (in line)
2025/Q2 2025-08-07 -- ±9.07% -0.53% (in line)
2024/Q4 2025-02-26 -- ±17.49% +5.34% (in line)
2024/Q2 2024-08-08 -- ±16.26% +2.76% (in line)
2023/Q4 2024-02-28 -- ±9.82% -1.76% (in line)
2023/Q2 2023-08-10 -- ±9.69% -3.67% (in line)
2022/Q4 2023-03-01 -- ±16.75% -1.46% (in line)
2022/Q2 2022-08-10 -- -- +4.27%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.

Immunocore discussion 0 comments

Add a comment